Stay updated on Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.2 to v3.6.3, indicating a new release version. The change does not alter visible content.
    Difference
    0.1%
    Check dated 2026-07-03T23:58:52.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer revision of the page. This reflects a recent update to the page content or its presentation rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-06-26T23:23:17.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now indicates that recruitment is closed, clarifying that no new participants will be enrolled. In addition, the navigation labels and the page revision label were updated to reflect the current version (v3.6.0).
    Difference
    0.5%
    Check dated 2026-06-12T16:40:46.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays revision v3.5.5, replacing v3.5.4, signaling a minor backend/content management update. No study content or results are affected.
    Difference
    0.1%
    Check dated 2026-06-05T12:47:08.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.5.3 to v3.5.4, indicating a minor update to the page's documentation or metadata rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-05-15T05:09:27.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page’s footer revision label has been updated from v3.5.2 to v3.5.3, reflecting a new site version rather than a change to the study’s content.
    Difference
    0.1%
    Check dated 2026-04-23T21:53:05.000Z thumbnail image

Stay in the know with updates to Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Neuroendocrine Tumors Clinical Trial page.